Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient - Université de Lille Accéder directement au contenu
Article Dans Une Revue Transplant Infectious Disease Année : 2020

Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient

Résumé

A 65-year-old man was diagnosed with an invasive Aspergillus fumigatus infection with sternal osteomyelitis 4 months after heart transplantation. Unfortunately, after 8 weeks patient developed severe cutaneous and neurological toxicities induced by voriconazole leading to drug discontinuation. Therefore, isavuconazole was chosen as second-line therapy. The patient presented a favorable outcome and tolerance was excellent after ten months monotherapy. Here, we report for a first time, an successful isavuconazole-based treatment of sternal osteomyelitis aspergillosis in a cardiac recipient.
Fichier non déposé

Dates et versions

hal-03324222 , version 1 (23-08-2021)

Identifiants

Citer

Ady Assaf, Emmanuel Faure, Kevin Sermet, Severine Loridant, Jordan Leroy, et al.. Successful treatment of Aspergillus fumigatus sternal osteomyelitis with isavuconazole in a heart transplant recipient. Transplant Infectious Disease, 2020, 22 (5), pp.e13313. ⟨10.1111/tid.13313⟩. ⟨hal-03324222⟩
43 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More